News Releases
Jul 1 2002
Peregrine Pharmaceuticals Provides Update on Status of Cotara Phase III and Schedules Quarterly Conference Call
Jun 24 2002
Avid Bioservices to Present At Biologics Manufacturing Conference
Jun 19 2002
Innovative Administration of Peregrine Pharmaceuticals' Radiolabeled TNT Successfully Treats Inoperable Lung Cancer
Jun 18 2002
Peregrine Pharmaceuticals Announces U.S. Patent Granted for New Cancer Treatment
Jun 17 2002
Patent for Peregrine Pharmaceuticals' Vasopermeation Enhancement Technology Issued
Jun 13 2002
New Class of Anti-Cancer Agents Highlighted At First International Conference On Vascular Targeting
Jun 11 2002
Peregrine's Vascular Targeting Agent Platform Selectively Destroys Blood Supply to Cancer Tumors in an Animal Model
Jun 10 2002
Peregrine Pharmaceuticals Presents Vascular Targeting Agent Technology At BIO 2002
May 21 2002
Peregrine Pharmaceuticals Presents Data On Vasopermeation Enhancement Agent Technology At American Society of Clinical Oncology Annual Meeting
May 14 2002
Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Development of Genetically Engineered TNT Antibody Fragments Expressed in Mammalian Cells